Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lai H et al. | 1999 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 50 µT–2 mT |
Sonnier H et al. | 2003 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, static magnetic field, 50/60 Hz | 0.072–7.5 mT |
Miller SC et al. | 1999 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, 50/60 Hz, power transmission line | 0.08–1.3 mT |
Sonnier H et al. | 2000 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, static magnetic field, 50/60 Hz | 80 µT–7.5 mT |
Kristupaitis D et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
Dibirdik I et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz | 100 µT |
Wetzel BJ et al. | 2001 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Zhou J et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 0.1 mT |
Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Martinez MA et al. | 2012 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.